In this work, an injection volume of 200 μL was set as this has previously been used for the delivery of an IGF-1 and HGF containing ureido-pyrimidinone hydrogel to the ventricle wall in a porcine model of MI [41]. The gene discussed is IGF1; the disease is myocardial infarction.